| 1 |
Duah Boakye Y, Kwankyewaa Adjei D, Oduro Yeboah K, Obeng Mensah D, Osafo N, Appiah Agana T, Etsiapa Boamah V, Agyare C. Natural Products as Therapeutic Option for Echinococcossis. Echinococcosis - New Perspectives [Working Title] 2023. [DOI: 10.5772/intechopen.109614] [Reference Citation Analysis]
|
| 2 |
Millsapps EM, Underwood EC, Barr KL. Development and Application of Treatment for Chikungunya Fever. Res Rep Trop Med 2022;13:55-66. [PMID: 36561535 DOI: 10.2147/RRTM.S370046] [Reference Citation Analysis]
|
| 3 |
Frej A, Cano M, Ruiz-Postigo JA, Macharia P, Phillips RO, Amoako YA, Carrion C. Assessing the Quality of the World Health Organization's Skin NTDs App as a Training Tool in Ghana and Kenya: Protocol for a Cross-sectional Study. JMIR Res Protoc 2022;11:e39393. [PMID: 36480252 DOI: 10.2196/39393] [Reference Citation Analysis]
|
| 4 |
Whittaker C, Chesnais CB, Pion SDS, Kamgno J, Walker M, Basáñez M, Boussinesq M. Factors associated with variation in single-dose albendazole pharmacokinetics: A systematic review and modelling analysis. PLoS Negl Trop Dis 2022;16:e0010497. [DOI: 10.1371/journal.pntd.0010497] [Reference Citation Analysis]
|
| 5 |
Whittaker C, Chesnais CB, Pion SD, Kamgno J, Walker M, Basáñez M, Boussinesq M. Factors associated with variation in single-dose albendazole pharmacokinetics: A systematic review and modelling analysis.. [DOI: 10.1101/2022.05.18.22275185] [Reference Citation Analysis]
|
| 6 |
Roseboom IC, Thijssen B, Rosing H, Alves F, Mondal D, Teunissen MBM, Beijnen JH, Dorlo TPC. Development and validation of an HPLC-MS/MS method for the quantification of the anti-leishmanial drug miltefosine in human skin tissue. J Pharm Biomed Anal 2022;207:114402. [PMID: 34634528 DOI: 10.1016/j.jpba.2021.114402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Zaidi AK, Dehgani-Mobaraki P. The mechanisms of action of ivermectin against SARS-CoV-2-an extensive review. J Antibiot (Tokyo) 2021. [PMID: 34931048 DOI: 10.1038/s41429-021-00491-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 8 |
Kip AE, Blesson S, Alves F, Wasunna M, Kimutai R, Menza P, Mengesha B, Beijnen JH, Hailu A, Diro E, Dorlo TPC. Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study. J Antimicrob Chemother 2021;76:1258-68. [PMID: 33677546 DOI: 10.1093/jac/dkab013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 9 |
Verrest L, Wasunna M, Kokwaro G, Aman R, Musa AM, Khalil EAG, Mudawi M, Younis BM, Hailu A, Hurissa Z, Hailu W, Tesfaye S, Makonnen E, Mekonnen Y, Huitema ADR, Beijnen JH, Kshirsagar SA, Chakravarty J, Rai M, Sundar S, Alves F, Dorlo TPC. Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients. Clin Pharmacokinet 2021. [PMID: 34105063 DOI: 10.1007/s40262-021-01036-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Pontes da Silva A, Azevedo Ferreira D, Braga Dantas B. TRIPANOSSOMÍASE AMERICANA: UMA ANÁLISE DOS CUSTOS HOSPITALARES NAS REGIÕES BRASILEIRAS. RIS 2021;8:267-280. [DOI: 10.35621/23587490.v8.n1.p267-280] [Reference Citation Analysis]
|
| 11 |
Carrion C, Robles N, Sola-Morales O, Aymerich M, Ruiz Postigo JA. Mobile Health Strategies to Tackle Skin Neglected Tropical Diseases With Recommendations From Innovative Experiences: Systematic Review. JMIR Mhealth Uhealth 2020;8:e22478. [PMID: 33382382 DOI: 10.2196/22478] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 12 |
Carrion C, Robles N, Sola-morales O, Aymerich M, Ruiz Postigo JA. Mobile Health Strategies to Tackle Skin Neglected Tropical Diseases With Recommendations From Innovative Experiences: Systematic Review (Preprint).. [DOI: 10.2196/preprints.22478] [Reference Citation Analysis]
|
| 13 |
Palomares-alonso F, Jung H, Vidal-cantú GC, Rojas-tomé IS, González-esquivel DF, De la Cruz VP, Hernández IG, Hernández GP, Pérez-severiano F, Castro N. Moringa oleifera Extracts and Praziquantel Combination: Bioavailability in Rats and Cysticidal Activity in a Murine Model. Rev Bras Farmacogn 2020;30:251-256. [DOI: 10.1007/s43450-020-00058-w] [Reference Citation Analysis]
|
| 14 |
Borborema SET, Osso JA, de Andrade HF, do Nascimento N. Pharmacokinetics of neutron-irradiated meglumine antimoniate in Leishmania amazonensis-infected BALB/c mice. J Venom Anim Toxins Incl Trop Dis 2019;25:e144618. [PMID: 31130998 DOI: 10.1590/1678-9199-JVATITD-1446-18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 15 |
Kip AE, Schellens JHM, Beijnen JH, Dorlo TPC. Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs. Clin Pharmacokinet 2018;57:151-76. [PMID: 28756612 DOI: 10.1007/s40262-017-0570-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 16 |
Souza Ribeiro Costa J, Medeiros M, Yamashiro-Kanashiro EH, Rocha MC, Cotrim PC, Stephano MA, Lancellotti M, Tavares GD, Oliveira-Nascimento L. Biodegradable nanocarriers coated with polymyxin B: Evaluation of leishmanicidal and antibacterial potential. PLoS Negl Trop Dis 2019;13:e0007388. [PMID: 31042710 DOI: 10.1371/journal.pntd.0007388] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 17 |
Jiménez-Antón MD, García-Calvo E, Gutiérrez C, Escribano MD, Kayali N, Luque-García JL, Olías-Molero AI, Corral MJ, Costi MP, Torrado JJ, Alunda JM. Pharmacokinetics and disposition of miltefosine in healthy mice and hamsters experimentally infected with Leishmania infantum. Eur J Pharm Sci 2018;121:281-6. [PMID: 29883726 DOI: 10.1016/j.ejps.2018.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 18 |
Muñoz J, Ballester MR, Antonijoan RM, Gich I, Rodríguez M, Colli E, Gold S, Krolewiecki AJ. Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers. PLoS Negl Trop Dis 2018;12:e0006020. [PMID: 29346388 DOI: 10.1371/journal.pntd.0006020] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 19 |
Hong ST. Albendazole and Praziquantel: Review and Safety Monitoring in Korea. Infect Chemother 2018;50:1-10. [PMID: 29637747 DOI: 10.3947/ic.2018.50.1.1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
|
